NXS.AX - Next Science Limited

ASX - ASX Delayed price. Currency in AUD
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
10,444
11,713
8,948
3,441
4,061
Cost of revenue
2,201
2,563
2,007
524.134
550.48
Gross profit
8,243
9,150
6,940
2,917
3,510
Operating expenses
Research development
5,538
6,150
4,479
5,954
1,732
Selling general and administrative
14,638
15,695
11,279
8,792
9,098
Total operating expenses
20,991
22,742
16,548
15,448
16,047
Operating income or loss
-12,748
-13,592
-9,608
-12,531
-12,536
Interest expense
2,999
-
-
-
2,101
Total other income/expenses net
263.903
27.89
257.864
533.227
73.695
Income before tax
-11,739
-12,683
-9,350
-11,912
-14,352
Income tax expense
0
0
0
0
0
Income from continuing operations
-11,739
-12,683
-9,350
-11,912
-14,352
Net income
-11,739
-12,683
-9,350
-11,912
-14,352
Net income available to common shareholders
-11,739
-12,683
-9,350
-11,912
-14,352
Basic EPS
-
-
-0.05
-0.06
-0.09
Diluted EPS
-
-
-0.05
-0.06
-0.09
Basic average shares
-
-
196,883
187,185
165,979
Diluted average shares
-
-
196,883
187,185
165,979
EBITDA
-
-12,695
-8,817
-11,830
-11,685